Overview #
Body oils and dry oil sprays are not just elegant textures — they are technically demanding formats where emollient selection, pump engineering, and skin feel outcomes are tightly coupled. Get the blend wrong and you either clog the atomizer or leave a greasy residue that kills repurchase. We’ve reformulated more than a few of these after brands came to us with exactly that complaint. The clinical evidence on key emollients is actually stronger than most brand owners realize, and it directly informs how we build these formulas from the ground up.
Emollient Chemistry and What the Evidence Actually Shows #
The three actives we reach for most often in dry oil formats are squalane, jojoba esters, and C12-15 alkyl benzoate. Each has a different performance profile, and the clinical data behind them is uneven — which matters when you’re writing claims for EU or US markets.
Squalane is the workhorse. In a double-blind, randomized controlled trial (n=44, 8 weeks, twice-daily application), squalane-based emollient treatment produced a 34% improvement in transepidermal water loss (TEWL) versus baseline, measured by Tewameter TM300. Skin hydration scores by Corneometer also improved 28% versus the vehicle control. What the study doesn’t capture — and what we see on our own stability panels — is that squalane’s oxidative stability at 40°C/75% RH holds cleanly past 18 months when sourced from sugarcane-derived material. Shark-derived squalane is still available but we stopped specifying it years ago. The sugarcane version is more consistent batch to batch anyway.
Jojoba esters behave differently. They’re not a liquid wax in the traditional sense — they’re transesterified, which gives them a semi-solid character that modifies skin feel in ways liquid jojoba oil doesn’t. A split-face study (n=30, 4 weeks) showed jojoba ester emollient at 5% concentration reduced visible skin roughness by 22% versus untreated control, assessed by optical profilometry. The texture contribution is real. The limitation is pump behavior: above 8% in a spray formula, we start seeing inconsistent atomization, especially in cold-fill conditions below 15°C. We’ve had two client projects where the brand insisted on 10% jojoba esters in a 100mL spray bottle. Both failed atomization QC in winter warehouse conditions. We now cap it at 6% for spray formats and compensate with lighter esters elsewhere.
C12-15 alkyl benzoate is the spreading agent that makes dry oils feel dry. It has the lowest viscosity of the three — typically 4–6 mPa·s at 25°C — and it accelerates skin absorption of the heavier emollients. The clinical evidence here is thinner. Most of what exists is supplier-generated sensory panel data rather than peer-reviewed RCTs. Internally we’ve observed faster rub-out times (under 45 seconds to non-tacky feel) when C12-15 alkyl benzoate is included at 15–20% of the total oil phase. Without it, rub-out typically runs 90–120 seconds. That’s the difference between a product that feels luxurious and one that feels greasy.
For deeper background on how we approach emollient layering in actives-forward formulas, see our vitamin C and antioxidant systems documentation — the oxidative stability principles carry over directly.
Pump Atomization: Where Most Spray Projects Actually Fail #
This is usually where projects go sideways. Brand owners focus on the oil blend and treat the pump as a commodity component. It isn’t.
For a dry oil spray to atomize correctly, the formula viscosity needs to sit between 8 and 25 mPa·s at 25°C. Below 8, you get dripping and poor spray pattern. Above 25, the pump struggles to generate consistent droplet size — you end up with a wet, uneven mist that pools on skin. We measure this on every batch before filling.
Droplet size matters more than most people think. Our target is 50–80 µm VMD (volume median diameter) for a body spray application. Below 50 µm and you’re generating inhalable aerosol fractions, which creates a regulatory flag in the EU under EU Cosmetics Regulation 1223/2009 — specifically around spray product safety assessments. Above 80 µm and the product feels wet on application rather than dry.
The pump itself: we’ve standardized on 0.14–0.16 mL per actuation for body oil sprays. Anything higher and consumers over-apply, which brings us back to the greasy feel complaint. We rejected our first packaging vendor on a 2022 project because their pump CV (coefficient of variation) across 20 actuations was 18% — way too inconsistent. We now require suppliers to demonstrate CV below 8% on actuation volume before we approve them for this format.
Fragrance load is another failure point. We’ve seen emulsion-adjacent instability in oil sprays when fragrance load exceeds 1.2% — the polar components in fragrance compounds interact with the ester phase and shift viscosity upward over time. Three out of five clients who request fragrance above 1.5% in a dry oil spray hit viscosity drift by week 6 of accelerated stability testing. We push back on this brief almost every time.
Evidence Strength: How the Three Key Emollients Compare #
| Emollient | Best Clinical Evidence | Study Design | Key Numeric Result | Claim Suitability |
|---|---|---|---|---|
| Squalane (sugarcane) | TEWL reduction, hydration | RCT, n=44, 8 weeks, DB | 34% TEWL improvement, 28% hydration vs. control | Strong — supports moisturization claims EU/US/NMPA |
| Jojoba Esters (5%) | Skin roughness reduction | Split-face, n=30, 4 weeks | 22% roughness reduction vs. untreated | Moderate — supports smoothing/texture claims |
| C12-15 Alkyl Benzoate | Rub-out / sensory | Internal sensory panel | <45 sec to non-tacky vs. 90–120 sec without | Weak for claims — functional/formulation use only |
Honestly, most brands underestimate how much the evidence tier matters when writing claims. C12-15 alkyl benzoate is doing real work in the formula, but you can’t build a consumer-facing claim around internal sensory data. Squalane is the one to lead with if you want substantiated claims in regulated markets.
For brands developing body care with barrier-repair positioning, our barrier repair and sensitive skin formulation notes cover how we layer emollients with ceramide and fatty acid systems — relevant if you’re targeting eczema-prone or post-procedure skin.
Skin Feel Data: What We Measure and Why It Matters #
Skin feel is subjective until you instrument it. We run three measurements on every dry oil spray batch before sign-off: Corneometer (hydration), Tewameter (TEWL), and a friction coefficient measurement using a Frictiometer FR700. The friction coefficient tells us whether the product is actually reducing skin drag — which correlates strongly with the “silky” descriptor consumers use in sensory panels.
Baseline friction coefficient on untreated forearm skin typically runs 0.55–0.65 in our lab conditions (22°C, 45% RH). A well-formulated dry oil spray should bring that down to 0.30–0.40 at 5 minutes post-application. If we’re still above 0.45 at 5 minutes, the formula needs adjustment — usually more C12-15 alkyl benzoate or a lighter ester like isononyl isononanoate.
The 24-hour hydration retention number is what brand partners care about most for marketing. In our internal testing, squalane-dominant formulas (>40% of oil phase) consistently show 18–22% hydration improvement over untreated skin at 24 hours. That’s a real number we can put behind a claim. Formulas where the oil phase is dominated by heavier emollients like caprylic/capric triglyceride without squalane tend to peak earlier and drop off faster — good initial feel, weaker 24-hour story.
We’re still not fully convinced the 24-hour data from our in-house Corneometer panels is equivalent to what a CRO would generate under ISO 24442 conditions. The direction is consistent, but the absolute numbers sometimes differ by 5–8 percentage points. We use our internal data for formulation decisions and recommend brands commission independent CRO testing before making 24-hour claims in EU markets.
Where Regulatory Claim Substantiation Gets Complicated #
Drop below pH 4.0 in a water-containing body oil emulsion and you’re in a different regulatory conversation in the EU. Most pure oil sprays avoid this entirely — no water phase, no pH issue. But the moment a brand asks for a “hydrating mist” hybrid with water content above 5%, the preservation and pH story changes completely.
For pure anhydrous dry oil sprays, the claim pathway is relatively clean across all three major markets:
EU: Cosmetic claims must comply with EU Cosmetics Regulation 1223/2009 and the associated Claims Regulation (EC) No 655/2013. “Moisturizing” and “skin-softening” claims require substantiation — supplier data is acceptable as a starting point, but independent clinical data is strongly preferred for premium positioning. The SCCS Scientific Opinion framework applies if you’re making any claims that approach drug-adjacent territory (e.g., “repairs skin barrier” can trigger scrutiny).
US (FDA): The FDA Cosmetics Guidelines framework is more permissive on claims than EU, but “drug claims” — anything implying treatment of a condition — will reclassify your product. “Moisturizes skin” is fine. “Treats dry skin disease” is not. For spray formats, the FDA’s draft guidance on spray cosmetics is worth reviewing before finalizing your claims deck.
NMPA (China): The NMPA Cosmetic Regulation framework requires efficacy testing data for functional claims filed under the new 2021 regulations. For body oils, “moisturizing” is a general claim category that requires Corneometer-based substantiation data submitted with registration. We’ve filed several body oil registrations under the new system — the data package is more demanding than most brands expect, especially for imported products.
The honest answer is that claim substantiation strategy should be decided before formulation is finalized, not after. We’ve had to reformulate products because the brand wanted EU claims that the original formula couldn’t support with available data. That’s an expensive lesson.
Formulation Notes for Brand Partners #
What market? What are you expecting on-pack? Those are the first two questions we ask when a body oil brief lands on our desk.
If you’re targeting EU with moisturization claims, we build around squalane at 35–45% of the oil phase, supported by jojoba esters at 4–6% and C12-15 alkyl benzoate at 15–18%. That combination gives us the clinical data backbone for TEWL and hydration claims, the texture profile consumers expect from a premium dry oil, and atomization behavior that stays within spec across temperature ranges.
If you’re targeting a clean beauty positioning — and a lot of our brand partners are — the ingredient list needs to be short and recognizable. We can build a five-ingredient dry oil spray that performs well and reads cleanly on pack. The trade-off is that you lose some of the sensory engineering that comes from a more complex ester blend.
Packaging is not an afterthought. Airless pump formats add $0.40–$0.80 per unit at MOQ 3,000 units. Most indie brands can’t absorb that at launch volumes, so we typically recommend a standard fine-mist trigger spray with a validated pump at entry MOQ, then transition to airless at scale. The formula doesn’t change — the pump spec does.
One thing we always flag: if you want a 100mL spray and a 30mL travel size in the same launch, confirm pump actuation volume separately for each SKU. We’ve seen brands assume the same pump works across both sizes. It usually doesn’t.
Frequently Asked Questions #
Q: Can we call it “dry oil” on pack if it contains any water?
Technically you can, but we’d advise against it — consumers and regulators both read “dry oil” as anhydrous. Above 3% water content, you’re in emulsion territory and the product behavior changes enough that the claim becomes misleading. Keep it below 1% if you want to use the dry oil descriptor confidently.
Q: We want a spray that works on both body and hair — is that one formula?
It can be, but the oil profile needs adjustment. Hair applications benefit from lighter esters and lower viscosity — typically 8–12 mPa·s versus 15–20 mPa·s for body. We’ve done dual-use formulas at 10–12 mPa·s that work reasonably well for both, but the body skin feel is slightly lighter than a dedicated body formula. Worth the trade-off if you’re managing SKU count.
Q: How much fragrance can we add without affecting stability?
We cap fragrance at 1.0–1.2% in dry oil spray formats. Above that, we’ve seen viscosity drift in accelerated stability testing (40°C, 12 weeks) in roughly 60% of cases. If your brand requires a stronger scent throw, we’d rather discuss a leave-on body lotion format where fragrance at 1.5–2.0% is more manageable.
Q: What’s the minimum order quantity for a custom dry oil spray?
Our standard MOQ for a custom formula in spray format is 1,000 units per SKU. Below that, the filling line setup cost makes the per-unit economics difficult. For brands testing multiple SKUs simultaneously, we can sometimes consolidate filling runs to reduce effective MOQ — worth discussing during brief intake.
Q: Do we need separate stability data for EU and NMPA registration?
Yes, effectively. EU requires stability data aligned with ICH Stability Guidelines principles — typically 12 weeks accelerated at 40°C/75% RH plus real-time data. NMPA under the 2021 regulations requires efficacy substantiation data (Corneometer for moisturizing claims) in addition to stability. The test protocols overlap partially, but the documentation packages are different. We recommend running both in parallel from the start to avoid delays.
Have a product concept in mind? Contact our formulation team to request a complimentary brief review.
© 2026 Mastracare.com. All rights reserved.
Unauthorized reproduction or distribution is prohibited.